Hormone Replacement Therapy News
"Ovarian Risk Amongst Combined Hormone Replacement Therapy
Users"
October 2, 2003
Women taking estrogen plus progestin were diagnosed as having
invasive ovarian cancer at a rate of 42 per 100,000 person-years
in comparison to the 15 per 100,000 person-years in the placebo
group. The Hormone Replacement Therapy study analyzed trial
data collected for the Women’s Health Initiative trial
involving 16,608 postmenopausal women who had not had a hysterectomy
at enrolment and were using a certain combination of Hormone
Replacement Therapy drugs. Study authors concluded, “The
possibility of an increased risk of ovarian cancer incidence
and mortality remains worrisome.”
For more information on Hormone Replacement Therapy contact
us to confer with a lawyer.
More Hormone Replacement Therapy News...
Wyeth Sued Over Prempro Once Again
Studies Support Isoflavones for Hot Flushes
Rate of Breast Cancer Drops With Decline in HRT Use
New Study Differentiates Characteristics of Cancer in HRT Users
Is Bioidentical Hormone Therapy Safe?
Jury Rules Prempro Caused Breast Cancer In HRT Trial
Study: Hormone Replacement Therapy Raises Ovarian Cancer Risk
If you are currently taking hormone replacement therapy,
the combination of estrogen and progestin, you are advised
to contact your doctor IMMEDIATELY
for hormone replacement therapy alternatives.
For more information on hormone replacement therapy alternatives
and your legal rights, please
contact a hormone replacement therapy lawyer.
Hormone Replacement Therapy Side Effects News-
Top of Page
|
